Cargando…

Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors

OBJECTIVE: Sodium glucose cotransporter-2 inhibitors (SGLT2i) exert cardiorenal protection in people with diabetes. By inducing glycosuria, SGLT2i predispose to genital infections. In addition, rare occurrence of Fournier’s gangrene (FG) has been reported. We aimed to investigate such association th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fadini, Gian Paolo, Sarangdhar, Mayur, De Ponti, Fabrizio, Avogaro, Angelo, Raschi, Emanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Clinical care education/Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777404/ https://www.ncbi.nlm.nih.gov/pubmed/31641524 http://dx.doi.org/10.1136/bmjdrc-2019-000725

Ejemplares similares

Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Fournier’s Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
por: Chowdhury, Tutul, et al.
Publicado: (2022)

Fournier Gangrene
por: Wolf, Chelsea T., et al.
Publicado: (2010)

Fournier’s gangrene
por: Cheung, Phoebe S. Y., et al.
Publicado: (2009)

Fournier gangrene
por: Parry, Nadiah
Publicado: (2015)

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
por: Gatti, Milo, et al.
Publicado: (2019)

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
por: Gatti, Milo, et al.
Publicado: (2020)

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
por: Bonora, Benedetta Maria, et al.
Publicado: (2020)

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
por: Raschi, Emanuel, et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors
por: Chow, Erica, et al.
Publicado: (2023)

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Fournier's Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our Experience
por: Dass, Ashwitha S., et al.
Publicado: (2019)

SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study
por: Wang, Tongtong, et al.
Publicado: (2020)

Fournier’s gangrene under SGLT-2 inhibitor therapy: A literature review and case report
por: Ellegård, Lisa, et al.
Publicado: (2020)

THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)

Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
por: Raschi, Emanuel, et al.
Publicado: (2022)

Management of unusual genital lymphedema complication after Fournier’s gangrene: a case report
por: Meyer Ganz, Oanna, et al.
Publicado: (2012)

Ultrasound in the diagnosis of Fournier's gangrene
por: Kube, Erika, et al.
Publicado: (2012)

Fournier's Gangrene: Current Practices
por: Mallikarjuna, M. N., et al.
Publicado: (2012)

A Case of Fournier's Gangrene
por: Kordahi, Anthony Maurice, et al.
Publicado: (2017)

Massive necrotizing Fournier's gangrene
por: Rivera-Alvarez, Fernando, et al.
Publicado: (2021)

Ultrasonic Debridement of Fournier Gangrene
por: Tanuma, Takahiro, et al.
Publicado: (2023)

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
por: Fusaroli, Michele, et al.
Publicado: (2022)

Observational research on sodium glucose co‐transporter‐2 inhibitors: A real breakthrough?
por: Raschi, Emanuel, et al.
Publicado: (2018)

Fournier's gangrene: two unusual cases.
por: Mulholland, C. K., et al.
Publicado: (1990)

Fournier's Gangrene: Report of 2 Cases
por: Hota, Prasan Kumar
Publicado: (2012)

Diagnosis of Fournier’s Gangrene on Bedside Ultrasound
por: Coyne, Christopher, et al.
Publicado: (2014)

A rare case of Fournier’s Gangrene
por: Sheehy, Sally-Ann, et al.
Publicado: (2016)

Fungal Fourniers Gangrene in an Immunocompromised Patient
por: Crowell, Winston, et al.
Publicado: (2015)

Towards zero mortality in Fournier's gangrene
por: Kuzaka, Bolesław, et al.
Publicado: (2013)

Fournier's Gangrene - Findings on Computed Tomography
por: Cullen, I. M., et al.
Publicado: (2007)

Coverage of the scrotum after Fournier’s gangrene
por: El-Sabbagh, Ahmed Hassan
Publicado: (2018)

Fournier gangrene due to Rhizobium Radiobacter
por: Sen, Volkan, et al.
Publicado: (2018)

A curious case of Fournier's gangrene
por: Amin, Amer, et al.
Publicado: (2019)

Fournier’s gangrene mimicking an acute epididymitis
por: Larsen, Kalee, et al.
Publicado: (2021)

Hyperbaric oxygen therapy in Fournier’s gangrene
por: de Bessa, José
Publicado: (2022)

Fournier’s Gangrene: validation of the severity index
por: Itaimi, Ahmed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sqhbnhf8clvmsuu7s9pqjg7hpt